Table 1.

Demographic and clinical characteristics of healthy controls and ACS patients.

Parameter		Healthy control (n = 24)	ACS patients (n = 30)	p value
Age		53.8 (5.14)	57.2 (8.62)	0.125
Sex	Male	15 (62.5)	18 (60)	0.851
	Female	9 (37.5)	12 (40)
Hematology	WBC	7629.7 (2064.3)	9206.1 (1998/09)	0.008*
	RBC	4,868,452.71 (43822.32)	4,372,421.48 (767,575.20)	0.004*
	HGB	13.28 (2.01)	12.70 (1.56)	0.018*
	HCT	40.12 (4.61)	38.17 (4.12)	0.019*
	MCV	86.88 (2.98)	86.07 (12.51)	0.484
	MCH	28.18 (1.85)	28.82 (2.22)	0.321
	MCHC	34.29 (0.97)	34.08 (1.07)	0.060
	PLT	232,352 (49,998.71)	216,878.22 (53,632.72)	0.267
	RDW	12.19 (2.07)	14.87 (2.01)	0.008*
	Neutrophil	3517.92 (1421.86)	5298 (2018.71)	< 0.001*
	Lymphocyte	2462.85 (898.14)	2218.28 (821.62)	0.201
	Monocyte	528.89 (201.08)	431.17 (108.20)	0.200
Biochemistry	FBS	90.81 (7.32)	128.52 (47.50)	< 0.001*
	A1C	5.89 (1.02)	6.82 (1.56)	< 0.001*
	ALT	21.27 (7.81)	28.75 (11.44)	0.002*
	AST	23.89 (5.61)	29.17 (12.81)	0.031*
	Chol	185.25 (45.6)	132.4 (35.2)	< 0.001
	TG	144.8 (73.1)	109.7 (64.4)	< 0.001
	LDL	111.7 (20.9)	74.5 (18.5)	< 0.001
	HDL	39.8 (6.9)	40.3 (6.2)	0.926

Note: Categorical and continuous variables are expressed as the mean (SD) and number (%), respectively. The p value was assessed using χ ² tests for categorical variables and the t‐test for continuous variables.

Abbreviations: A1C, hemoglobin A1C; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Chol, cholesterol; FBS, fasting blood sugar; HCT, hematocrit; HDL, high‐density lipoprotein. HGB, hemoglobin; LDL, low‐density lipoprotein; MCH, mean cell hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean cell volume; PLT, platelet; RBC, red blood cell; RDW, red cell distribution width; TG, triglyceride; WBC, white blood cell.

^* p < 0.05.